Michigan's cannabis market has a supply problem that everyone in the industry can recite from memory: too much flower, too many license holders, prices scraped down to the bone. But a different number deserves attention right now, one that points toward a demand-side fix instead of another round of consolidation talk. Baby Boomers - consumers roughly 60 to 78 years old - are consuming cannabis at rates the industry hasn't seen from this age group before, and the dollars behind that behavior are not small.
National purchasing data attributed to Headset puts Baby Boomer spending at about 12.6 percent of tracked U.S. cannabis sales over the twelve months ending in June 2026. Apply that share to Michigan's roughly $3.17 billion in 2025 sales and you land near $399 million in potential Boomer spending in that state alone. Layer in Ohio's newer recreational market, still finding its footing after adult-use sales launched in August 2024, and the two-state total edges toward half a billion dollars annually. These are estimates, not agency-reported figures - Michigan's Cannabis Regulatory Agency doesn't break out sales by generation - but the underlying signal is real, and it has operational consequences for how dispensaries staff their floors, train budtenders, and even choose the point-of-sale infrastructure that manages loyalty data and purchase history. Operators evaluating retail technology built for this kind of demographic segmentation, including platforms like the Maine dispensary POS platform, are already thinking about how transaction data can inform product mix rather than just ring up sales.
Why Older Buyers Shop Differently
The thing is, selling to a 65-year-old isn't the same business as selling to a 25-year-old, and treating them identically is where a lot of retail strategy goes sideways. University of Michigan polling on cannabis use among adults 50 and older found the top reasons for consumption were relaxation, sleep support, and pain-related use - not high-potency flower runs. That means budroom inventory built around ever-climbing THC percentages may be missing this customer entirely. Lower-dose edibles, tinctures, topicals, and balanced THC-CBD ratios are a better match for stated motivations, and dispensaries that stock accordingly - and train staff to explain the difference between a 5mg gummy and a 100mg vape cartridge - are positioned to capture repeat business from a demographic that isn't chasing intensity.
Service and Education as Competitive Differentiators
In a market where wholesale pricing has collapsed and margins are thin across nearly every SKU, service is one of the few levers left that doesn't show up on a compliant packaging label. A customer returning to cannabis after three or four decades away needs a real explanation of what's changed - concentrates, vape hardware, edibles with precise dosing, lab-tested COAs on every batch. That's a sales-floor investment, not a marketing campaign, and it's one Michigan's price-driven market has largely neglected while chasing volume.
The Compliance and Safety Context Operators Can't Skip
Growth in this segment comes with real caution flags. University of Michigan polling found 83 percent of Michigan adults 50 and older believe today's cannabis is stronger than what was available decades ago - and they're not wrong. Higher-potency products raise the stakes for older consumers who may also be managing prescription regimens, where drug interactions are a legitimate concern. Notably, roughly a third of monthly cannabis users in that age group reported never having discussed their use with a health care provider, and a meaningful share admitted to driving within two hours of consumption. None of that is an argument against serving this market. It's an argument for doing it responsibly - accurate labeling, no unsupported health claims, and staff trained to point customers toward professional guidance rather than freelance medical advice.
- Lower-dose and combination THC-CBD products may better match older consumers' stated reasons for use
- Staff training on interaction risks and product education matters more with this demographic
- Retailers should avoid implying therapeutic or medical benefits not supported by lab data or regulatory approval
- Point-of-sale and loyalty systems can help track purchasing patterns without replacing in-person guidance
Michigan's oversupply problem isn't going away because one generation starts buying more. But the assumption that the state has already found every available customer doesn't hold up against the data. There's a market here that's older, more cautious, and shopping for different reasons - and the operators who adjust their shelves and their sales training accordingly may find margin relief that production cuts alone can't deliver.
